fbpx
September 20, 2023

Most Adults With Alopecia Areata Untreated 1 Year After Dx Most Adults With Alopecia Areata Untreated 1 Year After Dx

TOPLINE: Nearly three-quarters of adults with alopecia areata (AA) were not receiving treatment 1 year after diagnosis, according to a retrospective cohort study using data from […]
September 20, 2023

Study Confirms Psoriasis Linked to Higher Heart Disease Risk Study Confirms Psoriasis Linked to Higher Heart Disease Risk

TOPLINE: In a large cross-sectional study, nearly one third of patients with severe psoriasis met criteria for coronary microvascular dysfunction. METHODOLOGY: Prior studies with small sample […]
September 19, 2023

European Commission Approves Ritlecitinib for Severe AA European Commission Approves Ritlecitinib for Severe AA

The European Commission has authorized the marketing of ritlecitinib to treat adults and adolescents 12 years of age and older with severe alopecia areata. This makes ritlecitinib […]
September 19, 2023

Combining Lasers to Maximize Results, Patient Satisfaction Combining Lasers to Maximize Results, Patient Satisfaction

SAN DIEGO – In the clinical experience of Mathew M. Avram, MD, JD, fractional lasers work best in combination with other devices and wavelengths when treating signs of photoaging, […]
September 18, 2023

When Treating Scars, ‘Rehabilitation’ is the Goal When Treating Scars, ‘Rehabilitation’ is the Goal

SAN DIEGO – Injecting a scar with intralesional steroids is a popular way to reduce its size and soften the surrounding tissue, but proper technique matters, according to […]
September 15, 2023

CHMP Recommends Marketing of Biologic for Atopic Dermatitis CHMP Recommends Marketing of Biologic for Atopic Dermatitis

The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has recommended marketing authorization of lebrikizumab for the treatment of adult and […]
September 14, 2023

High Rate of Subsequent Cancers in Merkel Cell Carcinoma High Rate of Subsequent Cancers in Merkel Cell Carcinoma

Patients with cutaneous Merkel cell carcinoma (MCC) have a higher risk of subsequently developing solid and hematologic cancers, according to a new analysis. In a cohort […]
September 12, 2023

Company Submits Supplemental NDA for Topical AD Treatment Company Submits Supplemental NDA for Topical AD Treatment

Arcutis Biotherapeutics has submitted a supplemental New Drug Application (sNDA) to the Food and Drug Administration for roflumilast cream 0.15% for the treatment of mild to […]
September 11, 2023

Can Skin Bleaching Lead to Cancer? Can Skin Bleaching Lead to Cancer?

SINGAPORE — Can the prolonged use of skin-lightening products, such as hydroquinone, lead to skin cancer? This question was posed by Ousmane Faye, MD, PhD, director […]
google.com, pub-5711488453051849, DIRECT, f08c47fec0942fa0